Institut AllergoSan Revenue and Competitors

Graz, Austria

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Institut AllergoSan's estimated annual revenue is currently $44.2M per year.(i)
  • Institut AllergoSan's estimated revenue per employee is $201,000

Employee Data

  • Institut AllergoSan has 220 Employees.(i)
  • Institut AllergoSan grew their employee count by 6% last year.

Institut AllergoSan's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$44.2M2206%N/AN/A
#2
$41.8M20826%N/AN/A
#3
$25.3M126-5%N/AN/A
#4
$58.1M2897%N/AN/A
#5
$25.9M129416%N/AN/A
#6
$15.3M7625%N/AN/A
#7
$21.1M10572%N/AN/A
#8
N/A6442%N/AN/A
#9
N/A5948%N/AN/A
#10
$14.9M7480%N/AN/A
Add Company

What Is Institut AllergoSan?

For more than 25 years, Institut AllergoSan has developed and researched products made from substances provided by nature. No matter what has been involved – probiotics, organic substances or orthomolecular medicine – our focus has always been on offering our customers scientific innovations committed to the holistic concept of humans and nature. Thanks to intensive collaboration with renowned scientists in the fields of medicine, biology, pharmacy and biochemistry, a naturopathic research and competence centre was established. Our products are selected according to the strictest quality criteria and meet the highest standards. Our objective is to find the best solutions available for complex health problems. Research Research into several aspects of probiotic medicine currently uses up a large part of the budget at Institut AllergoSan. Teams of researchers in Europe, America and Asia are currently working on concepts for new probiotic medication and nutritional supplements that will revolutionise many areas in medicine over the next couple of years. The medical use of probiotics to treat antibiotic-associated diarrhoea has been known for a long time. In 2008 this was widely published in the American Journal of Gastroenterology with the products of Institut AllergoSan being introduced to the general public of healthcare professionals. Over the next couple of years, Institut AllergoSan will continue to concentrate in particular on the development of indicationrelated and specific probiotics that can be used as nutritional supplements and dietary food along with any medical treatment for medical purposes without causing any side effects or needing time for the body to get used to it. In doing so, we are expecting the approval of scientifically based multi-strain probiotics for a series of new medical indications.

keywords:N/A

N/A

Total Funding

220

Number of Employees

$44.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Institut AllergoSan News

2022-04-19 - Gesellschaftsprojekt BioBienenApfel präsentiert: Sebastian Vettel und Andreas Gabalier schenken...

... und von erfolgreichen Partnern in Deutschland: DEKRA, Teekanne, Institut AllergoSan, AT&S, Karl-Franzens-Universität Graz.

2022-03-22 - Six Senses Kaplankaya hosting wellness festival Harvest ...

Anita Frauwallner – multispecies probiotic expert and founder of Institut AllergoSan. Dr Gabor Maté – Hungarian-Canadian physician, expert in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$80.2M2214%N/A
#2
$83.5M23017%N/A
#3
$83.5M23017%N/A
#4
$43.9M235-7%N/A
#5
$65.1M28211%N/A